In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53

Những quyển sách tương tự

• Radiosensitization of Non-Small Cell Lung Cancer Cells by the Plk1 Inhibitor Volasertib Is Dependent on the p53 Status
  Bằng: Van den Bossche, Jolien, et al.
  Được phát hành: (2019)
• Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia
  Bằng: Van den Bossche, Jolien, et al.
  Được phát hành: (2017)
• Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines
  Bằng: De Pauw, Ines, et al.
  Được phát hành: (2018)
• Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib
  Bằng: De Pauw, Ines, et al.
  Được phát hành: (2019)
• Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress
  Bằng: Deben, Christophe, et al.
  Được phát hành: (2018)